Pemetrexed–bevacizumab effective maintenance therapy for NSCLC

Pemetrexed in combination with bevacizumab is superior to bevacizumab alone when given as continuation maintenance therapy in patients with advanced nonsquamous non-small-cell lung cancer, results of the AVAPERL trial show.
Source: MedWire News - Lung Cancer - Category: Cancer & Oncology Source Type: news